Seemant Chaturvedi
@chaturvedineuro
Stroke neurologist and researcher. Stewart J. Greenebaum Endowed Professor of Stroke Neurology at U Maryland. Sports enthusiast. Views are my own
ID: 1231781597793456129
24-02-2020 03:24:26
1,1K Tweet
3,3K Takipçi
346 Takip Edilen
2/2 ECST2 unique in that it also included lower risk symptomatic pts. No suggestion that symptomatic pts had benefit from REVASC. This supports ongoing studies such as #SCORE Registry Thanh Nguyen 🇺🇦 Luciano Sposato 🇦🇷🇨🇦 Bijoy K Menon Shadi Yaghi World Stroke Org SVIN American Academy of Neurology